---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-26-000214"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2026-09-01T18:13:08+00:00"
generated_at: "2026-09-01T18:14:07.888527+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Regenerex Pharma discloses delinquent Q1/Q2 2026 10-Qs; 10-K filed late

## Summary
- 2025 Form 10-K filed after deadline; Q1 and Q2 2026 10-Qs not yet filed and delinquent.
- Company did not file Form 12b-25 notifications for the outstanding quarterly reports.
- Delay attributed to additional accounting, reconciliation, and review work related to 10-K and quarterly statements.
- Management working to complete and file outstanding reports as soon as practicable; no expected change to operations.

## SEC filing metadata
- accession: 0001472375-26-000214
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2026-09-01T18:13:08+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/0001472375-26-000214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000214/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-26-000214
- JSON: https://secwatch.observer/filing/0001472375-26-000214.json
- Plain text: https://secwatch.observer/filing/0001472375-26-000214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.